| Date |
PIC/S GMP Series |
| 202306 |
PIC/S GMP Annex 1 Manufacture of Sterile Medicinal Products <More...> |
| 202301 |
PIC/S GMP (PI 053-1) Q&A of HBEL (Jun2020) <More...> |
| 202212 |
PIC/S GMP (PI 043-1) Cross-contamination in Shared Facilities (Jul2018) <More...> |
| 202210 |
PIC/S GMP (PI 046-1) Guideline on Setting HBELs for Use in Risk Identification in The Manufacture of Different Medicinal Products in Shared Facilities (Jul2018) <More...> |
| 202209 |
PIC/S GMP (PE 009-16) Annex 2B Manufacturer of Biological Medicinal Substances and Products for Human Use <More...> |
| 202208 |
PIC/S GMP (PE 009-16) Annex 2A Manufacturer of Advanced Therapy Medicinal Products for Human Use <More...> |
| 202207 |
PIC/S GMP (PI 045-1) Guidelines on The Formalised Risk Assessment for Ascertaining The Appropriate GMP for Excipient of Medicinal Products for Human Use (Jul2018) <More...> |
| 202206 |
PIC/S GMP (PE 009-16) Annex 16 Certification by The AP and Batch Release <More...> |
| 202205 |
PIC/S GMP (PE 009-16) Annex 13 Manufacture of Investigational Medicinal Products <More...> |
